Limited enzymatic hydrolysis of soy protein enhances cholesterol absorption inhibition in Caco-2 cells

Taiwanese Journal of Agricultural Chemistry and Food Science

Volumn 47, Issue 1, 2009, Pages 1-8

  Tsou, May June ^a   Kao, Fuh Juin ^b   Jhuang, Jyun Bi ^c   Chiang, Wen Dee ^c  

^a CHUNG CHOU INSTITUTE OF TECHNOLOGY   (Taiwan)

^b MING CHUAN UNIVERSITY   (Taiwan)

^c TUNGHAI UNIVERSITY   (Taiwan)

Author keywords

Caco 2 cell; Cholesterol; Limited hydrolysis; Soy protein

Indexed keywords

GLYCINE MAX;

EID: 67949123116     PISSN: 16052471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Y. Popineau, B. Huchet, C. Larré and S. Bérot: Foaming and emulsifying properties of fractions of gluten peptides obtained by limited enzymatic hydrolysis and ultrafiltration. J. Cereal Sci., 35: 327-335 (2002).
2. K. D. Martinez, R. I. Baeza, F. Millan and A. M. R. Pilosof: Effect of limited hydrolysis of sunflower protein on the interactions with polysaccharides in foams. Food Hydrocoll, 19: 361-369 (2005).
3. Z. Y. Ju and A. Kilara: Gelation of hydrolysates of a whey protein isolate incuced by heat, proteinase, salts and acid. Inter. Dairy J., 8: 303-309 (1998).
4. D. Doucet, S. F. Gauthier and E. A. Foegeding: Rheological characterization of a gel formed during extensive enzymatic hydrolysis. J. Food Sci, 66: 711-715 (2001).
5. B. Kong and Y. L. Xiong: Antioxidant activity of zein hydrolysates in a liposome system and the possible mode of action. J. Agr. Food Chem., 54: 6059-6068 (2006).
6. K. Zhu, H. Zhou and H. Qian: Antioxidant and free radical-scavenging activities of wheat germ protein hydrolysates (WGPH) prepared with alcalase. Proc. Biochem., 41: 1296-1302 (2006).
7. W. D. Chiang, M. J. Lee, W. S. Guo and T. C. Tasi: Protein hydrolysate batch production with angiotensin I-converting enzyme ihhibitory from egg whites. J. Food Drug Anal., 14: 385-390 (2006).
8. W. D. Chiang, M. J. Tsou, Z. Y. Tsai and T. C. Tasi: Angiotensin I-converting enzyme derived from soy protein hydrolysate and produced by using membrane reactor. J. Food Chem., 98: 725-732 (2006).
9. W. D. Chiang, M. J. Tsou, C. H. Weng and T. C. Tasi: Production fo angiotensin I-converting enzyme inhibitor derived from egg white protein hydrolysates using a membrane reactor. J. Food Drug Anal., 16: 54-60 (2008).
10. S. Nagaoka, T. Awano, N. Nagata, M. Masaoka, G. Hori and K. Hashimoto: Serum cholesterol reduction and cholesterol absorption inhibition in Caco-2 cells by a soyprotein peptic hydrolyzate. Biosci. Biotech. Biochem., 61: 354-356 (1997).
11. H. Wergedahl, B. Liaset, O. A. Gudbrandsen, E. Lied, Z. Muna, S. Mork and R. K. Berge: Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J. Nutr., 134: 1320-1327 (2004).
12. N. Vaghefi, F. Nedjaoum, D. Guillochon, F. Bureau, P. Arhan and D. Bougie: Iron absorption from concentrated hemoglobin hydrolysate by rat. J. Nutr. Biochem., 16: 347-352 (2005).
13. G. A. Biziulevicius, V. Zukaite, T. Normantiene, G. Biziuleviciene and I. G. Arestov: Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis. FEMS Immuno Medical Microbio., 39: 155-161 (2003).
14. W. B. Kannel, W. P. Castelli, T. Gordon and P. M. McNamara: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Annals Internal. Med., 74: 1-12 (1971).
15. M. J. Martin, S. B. Hulley, W. S. Browner, L. H. Kuller and D. Wenworth: Serum cholesterol, blood pressure and mortality: implications from a cohort of 361, 662 men. Lancet, 2: 933-936 (1986).
16. J. Stamler, M. L. Daviglus, D. B. Garside, A. R. Dyer, P. Greenland and J. Neaton: Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J. Am. Med. Assoc, 284: 311-318(2000).
17. K. K. Carroll: Review of clinical studies on cholesterol-lowering response to soy protein. J. Am. Diet Assoc, 91: 820-827 (1991).
18. J. W. Erdman and E. J. Fordyce: Soy products and human diet. Am. J. Clin. Nutr., 49: 725-737 (1989).
19. U.S. Food and Drug Administration, FDA final rule for food labeling: health claims; soy protein and coronary heart disease. Fed. Regist., 64: 57699-57733 (1999).
20. M. Sugano, S. Goto, Y. Yamada, K. Yoshida, Y. Hashimoto, T. Matsuo and M. Kimoto: Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J. Nutr., 120: 977-985 (1990).
21. S. Nagaoka, K. Miwa, M. Eto, Y. Kuzuya, G. Hori and K. Yamamoto: Soy protein peptic hydrolysate with bound phospholipids decreases micellar solubility and cholesterol absorption in rats and Caco-2 cells. J. Nutr., 129: 1725-1730 (1999).
22. J. Adler-Nissen: Limited enzymic degradation of proteins: a new approach in the industrial application of hydolases. J. Chem. Tech. Biotechnol., 32: 138-156 (1982).
23. H. Frister, H. Meisel and E. Schlimme: OPA method modified by use of N,N-dimethyl-2- mercaptoehylammonium chlorides as thiol component. Fresenius. Z. Anal. Chem., 330: 631-633 (1998).
24. AOCS, Official Methods and Recommended Practices of the American Oil Chemists' Society (4th ed.). Champaign, IL (1989).
25. C. Kirana, P. F. Rogers, L. E. Bennett, M. Y. Abeywardena and G. S. Patten: Rapid screening for potential cholesterol-lowering peptides using naturally derived micelle preparation. Australian J. Dairy Techno., 60: 163-166 (2005).
26. D. G. Raederstorff, M. F. Schlachter, V. Elste and P. Weber: Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem., 14: 326-332 (2003).